Development of bi-polymer lipid hybrid nanocarrier (BLN) to improve the entrapment and stability of insulin for efficient oral delivery

[1]  Ping Yao,et al.  Fatty acid and quaternary ammonium modified chitosan nanoparticles for insulin delivery. , 2018, Colloids and surfaces. B, Biointerfaces.

[2]  J. Bulte,et al.  Oral Administration of Salecan-Based Hydrogels for Controlled Insulin Delivery. , 2018, Journal of agricultural and food chemistry.

[3]  A. Grigoras.  Polymer-lipid hybrid systems used as carriers for insulin delivery. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[4]  Min Liu,et al.  Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Mayyas Al-Remawi,et al.  Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system , 2017, Pharmaceutical development and technology.

[6]  K. Korzekwa,et al.  Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery. , 2016, International journal of pharmaceutics.

[7]  B. Mishra,et al.  Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes. , 2016, Nanomedicine.

[8]  G. Fetih,et al.  Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery. , 2016, Journal of pharmaceutical sciences.

[9]  A. Florence.  Oral insulin delivery: a chimera? , 2015, International journal of pharmaceutics.

[10]  E. M. Lima,et al.  Biodegradable nanoparticles designed for drug delivery: The number of nanoparticles impacts on cytotoxicity. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  Atul Kolate,et al.  PEG - a versatile conjugating ligand for drugs and drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[12]  H. Wong,et al.  A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  E. Chan,et al.  Particle designs for the stabilization and controlled-delivery of protein drugs by biopolymers: a case study on insulin. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[14]  David J Brayden,et al.  Formulation strategies to improve oral peptide delivery. , 2014, Pharmaceutical patent analyst.

[15]  Hyun-Jong Cho,et al.  Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake , 2014, International journal of nanomedicine.

[16]  E. Mathiowitz,et al.  Oral delivery of proteins by biodegradable nanoparticles. , 2013, Advanced drug delivery reviews.

[17]  S. Boddu,et al.  Approaches for enhancing oral bioavailability of peptides and proteins. , 2013, International journal of pharmaceutics.

[18]  Deying Cao,et al.  Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  C. Reis,et al.  Nanotechnology as a promising strategy for alternative routes of insulin delivery. , 2012, Methods in enzymology.

[20]  B. Sarmento,et al.  Chitosan formulations as carriers for therapeutic proteins. , 2011, Current drug discovery technologies.

[21]  G. Singh,et al.  Oral Insulin Delivery with Various Grades of HPMC on Non-Diabetic Rats , 2011 .

[22]  C. Thompson,et al.  Uptake and Transport of Novel Amphiphilic Polyelectrolyte-Insulin Nanocomplexes by Caco-2 Cells—Towards Oral Insulin , 2011, Pharmaceutical Research.

[23]  M. Ibrahim.  Sci Pharm www.scipharm.at Research article Open Access Assessment of Insulin Stability Inside , 2022 .

[24]  C. Sharma,et al.  Challenges and advances in nanoparticle-based oral insulin delivery , 2009, Expert review of medical devices.

[25]  F. Veronese,et al.  PEGylation for improving the effectiveness of therapeutic biomolecules. , 2009, Drugs of today.

[26]  D. Chirio,et al.  Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation , 2009, Journal of microencapsulation.

[27]  S. Doktorovová,et al.  Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery. , 2009, Methods in enzymology.

[28]  Wenzhong Zhou,et al.  Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. , 2008, Colloids and surfaces. B, Biointerfaces.

[29]  M. Rafiee-Tehrani,et al.  Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies. , 2008, International journal of pharmaceutics.

[30]  Yoshinori Onuki,et al.  Current challenges in non-invasive insulin delivery systems: a comparative review. , 2007, Advanced drug delivery reviews.

[31]  B. Sarmento,et al.  Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles , 2007, International journal of nanomedicine.

[32]  A. Almeida,et al.  Solid lipid nanoparticles as a drug delivery system for peptides and proteins. , 2007, Advanced drug delivery reviews.

[33]  M. Gallarate,et al.  Solid lipid nanoparticles formed by solvent-in-water emulsion–diffusion technique: Development and influence on insulin stability , 2007, Journal of microencapsulation.

[34]  N. Zhang,et al.  Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. , 2006, International journal of pharmaceutics.

[35]  M Uner,et al.  Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. , 2006, Die Pharmazie.

[36]  Claudia Fruijtier-Pölloth.  Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. , 2005, Toxicology.

[37]  D. Fischer,et al.  Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells , 2005, Pharmaceutical Research.

[38]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[39]  Eric Doelker,et al.  Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  J. Benoit,et al.  Why Does PEG 400 Co-Encapsulation Improve NGF Stability and Release from PLGA Biodegradable Microspheres? , 1999, Pharmaceutical Research.

[41]  H. Tajerzadeh,et al.  A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high-performance liquid chromatography. , 2003, Journal of pharmaceutical and biomedical analysis.

[42]  M. Wirth,et al.  Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres. , 2003, International journal of pharmaceutics.

[43]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[44]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  P E Nolan,et al.  Selective stability-indicating high-performance liquid chromatographic assay for recombinant human regular insulin. , 1995, Journal of chromatography. A.

[46]  R. Müller,et al.  Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery , 1995 .